Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer
Far Eastern Memorial Hospital
1 other identifier
observational
50
1 country
1
Brief Summary
To compare dose-dense chemotherapy with intraperitoneal chemotherapy in patients with advanced stage ovarian cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2019
CompletedFirst Posted
Study publicly available on registry
October 22, 2019
CompletedStudy Start
First participant enrolled
October 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedJune 29, 2020
June 1, 2020
5 months
October 19, 2019
June 25, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Progression-free survivals between this intraveous and intraperitoneal chemotherapy groups
months
10 years
Secondary Outcomes (1)
Overall survivals between this two groups
10 years
Interventions
Intraperitoneal or intravenous dose-dense platinum/taxane chemotherapy
Eligibility Criteria
All consecutive women, who underwent intravenous dose-dense or intraperitoneal chemotherapy as the front-line chemotherapy were reviewed.
You may qualify if:
- Women with FIGO stage II\~IV ovarian cancer
- At least one cycle of intravenous dose-dense or intraperitoneal chemotherapy had been administered as the front-line chemotherapy.
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, 22050, Taiwan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Department of Obstetrics & Gynecology, Associate Professor
Study Record Dates
First Submitted
October 19, 2019
First Posted
October 22, 2019
Study Start
October 28, 2019
Primary Completion
March 31, 2020
Study Completion
March 31, 2020
Last Updated
June 29, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share